Saikosaponin B2
Product Specifications
CAS Number
58316-41-9
Target
HCV Protease
Related Pathways
Microbiology/Virology|||Proteases/Proteasome
Purity
0.9988
Bioactivity
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 ?M) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyrosinase and melanogenesis.
Smiles
[H][C@@]1(O[C@H]2[C@@H](O)[C@@H](C)O[C@@]([H])(O[C@H]3CC[C@@]4(C)[C@@]([H])(CC[C@]5(C)[C@]4([H])C=CC4=C6CC(C)(C)CC[C@]6(CO)[C@H](O)C[C@@]54C)[C@]3(C)CO)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Molecular Formula
C42H68O13
Molecular Weight
780.98
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1072292-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O17:K52:H18 L-fucose mutarotase (fucU)
Ask
View Details